You are here: Industry Insights > Breast Cancer

News List

New breast cancer protein discovered pharmatimes
January 03, 2019
Researchers from Cardiff University have discovered a protein driving aggressive breast cancer, which they say could be targeted for developing new and improved therapies.
Myriad study shows breast cancer recurrence test can predict therapy responses fiercebiotech
December 28, 2018
Myriad Genetics presented new data on its EndoPredict test, saying it can accurately forecast which women with newly diagnosed ER-positive, HER2-negative breast cancer will see the most benefits from adjunctive chemotherapy.....
Lilly lays out sunny 2019 forecast driven by growth of new diabetes, psoriasis and cancer drugs fiercepharma
December 25, 2018
Shares of Eli Lilly were up nearly 3% in premarket trading on Wednesday after the company provided a revenue and profit forecast for next year that beat analysts’ expectations.
Treatments of Breast Cancer and Main Drugs zhulikou431
December 25, 2018
Treatments of breast cancer mainly include surgical treatment, chemotherapy, radioactive therapy, endocrine therapy, targeted therapy, TCM treatment, and immune preparation treatment, etc.
Breast cancer clinical trials: top drugs under investigation pharmaceutical-technology
December 25, 2018
Breast cancer is the most commonly diagnosed cancer in women, the second most commonly diagnosed cancer overall, and is the fifth largest cause of cancer mortality worldwide.
New clinical trial reduces breast cancer radiotherapy side effects pharmatimes
December 24, 2018
A practice-changing new clinical trial has been found to reduce long-term radiotherapy side effects in women with breast cancer.
Lilly lays out sunny 2019 forecast driven by growth of new diabetes, psoriasis and cancer drugs fiercepharma
December 20, 2018
Shares of Eli Lilly were up nearly 3% in premarket trading on Wednesday after the company provided a revenue and profit forecast for next year that beat analysts’ expectations.
Breast cancer chatbot to launch in US December 20, 2018
A chatbot helping patients with breast cancer is to hit the key US market after attracting in 10,000 users in its home market of France.
NICE expands its recommendation for Oncotype Dx test pharmaceutical-technology
December 20, 2018
The UK’s pricing regulator the National Institutes of Health and Care Excellence (NICE) has expanded its guidance for Genomic Health’s Oncotype Dx Breast Recurrence Score to include early lymph node (LN)-negative breast cancer......
FDA agrees to review Roche’s Tecentriq combination for breast cancer pharmaceutical-technology
December 18, 2018
The US Food and Drug Administration (FDA) has accorded priority review status to the supplemental biologics licence application (sBLA) of Roche’s Tecentriq (atezolizumab) as a combination therapy for breast cancer......

Previous page 1 2 3 4 5 6 7 8 9 10 ... 26 27 Next page